Medtronic plc, IE00BTN1Y115

Medtronic stock gets FDA clearance for Hugo general surgery

Published on 11/21/2026 at 11:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic stock enters the new week after FDA clearance widened Hugo's US surgical reach. The decision expands the platform beyond urology.

Hugo expands Medtronic's surgical reach

  • The FDA cleared Hugo for a broad range of upper and lower abdominal general surgery procedures in the United States.
  • The clearance expands the system beyond its previous urology focus and opens access to a wider hospital market.
  • Medtronic is due to report its fiscal second-quarter results on November 24.
Medtronic plc, IE00BTN1Y115, Illustration mit AI erstellt.

Medtronic's Hugo robotic-assisted surgery system gained broader access to the US hospital market during the week ended Friday, November 20. On Tuesday, November 17, the U.S. Food and Drug Administration cleared Hugo for general surgery procedures, according to the Medtronic press release.

FDA clearance broadens Hugo's market

The authorization covers upper abdominal procedures including gallbladder removal, Roux-en-Y gastric bypass, ventral hernia repair and small bowel resection. It also covers appendectomy and inguinal hernia procedures in the lower abdomen.

Medtronic said the combined procedures represent about 3.5 million surgeries each year in the United States, more than half of the country's soft-tissue procedures. The decision extends Hugo beyond its earlier urology indication and allows hospitals to consider the system across a wider range of operating rooms.

Execution remains the next test

The company said Hugo procedure growth globally is running at more than twice the robotic-surgery market and that the system is on track to exceed 50,000 procedures by the end of its fiscal year. Those figures point to adoption as the next commercial test after the regulatory expansion.

Medtronic stock traded at 91.07 euros on Lang & Schwarz at 11:43 CET on Saturday, November 21.

Medtronic at a glance

  • Company: Medtronic plc
  • ISIN: IE00BTN1Y115
  • Primary listing: New York Stock Exchange
  • Lang & Schwarz quote: 91.07 euros at 11:43 CET on Saturday, November 21, 2026

The broader US equity market remains the key trading backdrop for Medtronic stock; see Current market reports.

For more news and analysis, visit More news and analyses on Medtronic stock.

Disclaimer...
en | IE00BTN1Y115 | MEDTRONIC PLC | boerse | 70542201 | bgmi